Molecular basis of factor H R1210C association with ocular and renal diseases

Journal of the American Society of Nephrology

Volumn 27, Issue 5, 2016, Pages 1305-1311

  Recalde, Sergio ^a   Tortajada, Agustin ^b   Subias, Marta ^b   Anter, Jaouad ^b   Blasco, Miquel ^c   Maranta, Ramona ^d   Coco, Rosa ^e   Pinto, Sheila ^b   Noris, Marina ^d   García Layana, Alfredo ^a   De Córdoba, Santiago Rodríguez ^b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d MARIO NEGRI INST PHARMACOL RES   (Italy)

^e UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; HUMAN SERUM ALBUMIN; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H, HUMAN;

ADULT; AGE RELATED MACULAR DEGENERATION; ARTICLE; C3 GLOMERULOPATHY; COHORT ANALYSIS; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC RISK; GLOMERULOPATHY; HEMOLYTIC UREMIC SYNDROME; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MOLECULAR GENETICS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SURFACE PLASMON RESONANCE; FEMALE; GENETICS; GLOMERULUS; KIDNEY DISEASE; MACULAR DEGENERATION; MALE; MIDDLE AGED; MUTATION; PEDIGREE;

ATYPICAL HEMOLYTIC UREMIC SYNDROME; COMPLEMENT C3; COMPLEMENT FACTOR H; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MACULAR DEGENERATION; MALE; MIDDLE AGED; MUTATION; PEDIGREE;

EID: 85016109442     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015050580     Document Type: Article

References (32)

1. Ricklin D, Hajishengallis G, Yang K, Lambris JD: Complement: A key system for immune surveillance and homeostasis. Nat Immunol 11: 785-797, 2010
2. Holers VM: The spectrum of complement alternative pathway-mediated diseases. Immunol Rev 223: 300-316, 2008
3. Rodríguez de Córdoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sánchez-Corral P: The human complement factor H: Functional roles, genetic variations and disease associations. Mol Immunol 41: 355-367, 2004
4. Noris M, Remuzzi G: Atypical hemolyticuremic syndrome. N Engl J Med 361: 1676-1687, 2009
5. Xiao X, Pickering MC, Smith RJ: C3 glomerulopathy: The genetic and clinical findings in dense deposit disease and C3 glomerulonephritis. Semin Thromb Hemost 40: 465-471, 2014
6. Gorin MB: Genetic insights into age-related macular degeneration: Controversies addressing risk, causality, and therapeutics. Mol Aspects Med 33: 467-486, 2012
7. Pérez-Caballero D, González-Rubio C, Gallardo ME, Vera M, López-Trascasa M, Rodríguez de Córdoba S, Sánchez-Corral P: Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet 68: 478-484, 2001
8. Caprioli J, Bettinaglio P, Zipfel PF, Amadei B, Daina E, Gamba S, Skerka C, Marziliano N, Remuzzi G, Noris M; Italian Registry of Familial and RecurrentHUS/TTP: Themolecular basis of familial hemolytic uremic syndrome: Mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 12: 297-307, 2001
9. RichardsA, BuddlesMR, Donne RL, Kaplan BS, Kirk E, Venning MC, Tielemans CL, Goodship JA, Goodship TH: Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am J HumGenet 68: 485-490, 2001
10. Edwards AO, Ritter R 3rd, Abel KJ,Manning A, Panhuysen C, Farrer LA: Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424, 2005
11. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R: A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to agerelatedmacular degeneration. Proc Natl Acad Sci U S A 102: 7227-7232, 2005
12. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA: Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421, 2005
13. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J: Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389, 2005
14. Licht C, Heinen S, Józsi M, Löschmann I, Saunders RE, Perkins SJ, Waldherr R, Skerka C, KirschfinkM, Hoppe B, Zipfel PF: Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). Kidney Int 70: 42-50, 2006
15. de Córdoba SR, de Jorge EG: Translational mini-review series on complement factor H: Genetics and disease associations of human complement factor H. Clin Exp Immunol 151: 1-13, 2008
16. Martinez-Barricarte R, Pianetti G, Gautard R, Misselwitz J, Strain L, Fremeaux-Bacchi V, Skerka C, Zipfel PF, Goodship T, Noris M, Remuzzi G, de Cordoba SR; European Working Party on the Genetics of HUS: The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 19: 639-646, 2008
17. Raychaudhuri S, Iartchouk O, Chin K, Tan PL, Tai AK, Ripke S, Gowrisankar S, Vemuri S, Montgomery K, Yu Y, Reynolds R, Zack DJ, Campochiaro B, Campochiaro P, Katsanis N, Daly MJ, Seddon JM: A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet 43: 1232-1236, 2011
18. Zhan X, Larson DE, Wang C, Koboldt DC, Sergeev YV, Fulton RS, Fulton LL, Fronick CC, Branham KE, Bragg-Gresham J, Jun G, Hu Y, Kang HM, Liu D, OthmanM, BrooksM, Ratnapriya R, Boleda A, Grassmann F, von Strachwitz C, Olson LM, Buitendijk GH, Hofman A, van Duijn CM, Cipriani V, Moore AT, Shahid H, Jiang Y, Conley YP, Morgan DJ, Kim IK, Johnson MP, Cantsilieris S, Richardson AJ, Guymer RH, Luo H, Ouyang H, Licht C, Pluthero FG, ZhangMM, Zhang K, Baird PN, Blangero J, Klein ML, Farrer LA, DeAngelis MM, Weeks DE, Gorin MB, Yates JR, Klaver CC, Pericak-Vance MA, Haines JL, Weber BH, Wilson RK, Heckenlively JR, Chew EY, Stambolian D,Mardis ER, Swaroop A, Abecasis GR: Identification of a rare coding variant in complement 3 associated with age-relatedmacular degeneration. Nat Genet 45: 1375-1379, 2013
19. Seddon JM, Reynolds R, Yu Y, Rosner B: Three new genetic loci (R1210C in CFH, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration. PLoS One 9: e87047, 2014
20. Servais A, Frémeaux-Bacchi V, LequintrecM, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F: Primary glomerulonephritis with isolated C3 deposits: A new entity which shares common genetic risk factors with haemolytic uraemic syndrome. JMed Genet 44: 193-199, 2007
21. Manuelian T, Hellwage J, Meri S, Caprioli J, Noris M, Heinen S, Jozsi M, Neumann HP, Remuzzi G, Zipfel PF: Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest 111: 1181-1190, 2003
22. Sánchez-Corral P, Pérez-Caballero D, Huarte O, Simckes AM, Goicoechea E, López-Trascasa M, de Córdoba SR: Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. Am J Hum Genet 71: 1285-1295, 2002
23. BlaumBS, Hannan JP, Herbert AP, Kavanagh D, Uhrín D, Stehle T: Structural basis for sialic acid-mediated self-recognition by complement factor H. Nat Chem Biol 11: 77-82, 2015
24. Clark SJ, Perveen R, Hakobyan S,Morgan BP, Sim RB, Bishop PN, Day AJ: Impaired binding of the age-relatedmacular degenerationassociated complement factor H 402H allotype to Bruch's membrane in human retina. J Biol Chem285: 30192-30202, 2010
25. Prosser BE, Johnson S, Roversi P, Herbert AP, Blaum BS, Tyrrell J, Jowitt TA, Clark SJ, Tarelli E, UhrínD, Barlow PN, Sim RB, Day AJ, Lea SM: Structural basis for complement factor H linked age-related macular degeneration. J Exp Med 204: 2277-2283, 2007
26. Weismann D, Hartvigsen K, Lauer N, Bennett KL, Scholl HP, Charbel Issa P, Cano M, Brandstätter H, Tsimikas S, Skerka C, Superti-Furga G, Handa JT, Zipfel PF, Witztum JL, Binder CJ: Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478: 76-81, 2011
27. Dragon-Durey MA, Frémeaux-Bacchi V, Loirat C, Blouin J, Niaudet P, Deschenes G, Coppo P, Herman Fridman W, Weiss L: Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: Report and genetic analysis of 16 cases. J AmSocNephrol 15: 787-795, 2004
28. Hakobyan S, Tortajada A, Harris CL, de Córdoba SR, Morgan BP: Variant-specific quantification of factor H in plasma identifies null alleles associatedwith atypical hemolytic uremic syndrome. Kidney Int 78: 782-788, 2010
29. Montes T, Goicoechea de Jorge E, Ramos R, GomäM, PujolO, Sánchez-Corral P,Rodríguez de Córdoba S: Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis. Mol Immunol 45: 2897-2904, 2008
30. Rosenblad T, Rebetz J, Johansson M, Békássy Z, Sartz L, Karpman D: Eculizumab treatment for rescue of renal function in IgA nephropathy. Pediatr Nephrol 29: 2225-2228, 2014
31. Martínez-Barricarte R, Recalde S, Fernández-Robredo P, Millán I, Olavarrieta L, Viñuela A, Pérez-Pérez J, García-Layana A, Rodríguez de Córdoba S; SpanishMulticenter Group on AMD: Relevance of complement factor Hrelated 1 (CFHR1) genotypes in age-related macular degeneration. Invest Ophthalmol Vis Sci 53: 1087-1094, 2012
32. Sánchez Chinchilla D, Pinto S, Hoppe B, Adragna M, Lopez L, Justa Roldan ML, Peña A, Lopez Trascasa M, Sánchez-Corral P, Rodríguez de Córdoba S: Complement mutations in diacylglycerol kinase-associated atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 9: 1611-1619, 2014